Business Practice

Sitting Down With… Vered Caplan, CEO of Orgenesis, Israel.

Why the UK can hold its head high in the drive for pharma innovation.

The COVID-19 vaccines demonstrate what’s possible when disease is tackled as a genuine priority.

Criminal charges, drug pricing, and upgraded headquarters… What’s new in business?

Nominations for The Medicine Maker Power List will close on February 1.

We curate the COVID-19 news and breakthroughs of 2020 to bring you a helicopter view of the global fight against COVID-19.

To ensure the cell and gene therapy field advances with all stakeholders in mind, especially the patient, we need to talk – now.

What makes a good pharma employer? A survey asked over 7,000 people this question to determine the ingredients required for a positive work culture.

Sitting Down With... Anne Phelan, Chief Scientific Officer at BenevolentAI.

How can artificial intelligence improve access to novel therapeutics?